ArticleFrontiers in pediatrics2025
Overcoming barriers to care for individuals with fetal alcohol spectrum disorder: challenges and solutions in New Mexico and beyond.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal Alcohol Spectrum Disorder (FASD) encompasses a range of neurodevelopmental impairments caused by prenatal alcohol exposure, affecting cognitive, behavioral, and social functioning. Despite its high prevalence, FASD remains underdiagnosed, particularly in regions like New Mexico (NM), where high rates of alcohol use, poverty, and unplanned pregnancies exacerbate the burden of the disorder. Individuals with FASD often face significant challenges in adaptive functioning, education, and social integration, with many experiencing adverse childhood events that compound developmental difficulties. Access to appropriate healthcare and social services is hindered by diagnostic complexity, stigma, and exclusion from disability benefits. Limited awareness among healthcare providers, educators, and social workers further impedes early intervention, leading to increased risks of poor academic performance, unemployment, homelessness, and criminal justice involvement. Specialized FASD clinics play a critical role in diagnosis and support, but remain insufficient to meet the needs of affected individuals. Expanding education, advocacy, and tailored support services is essential to addressing these gaps. By enhancing awareness, integrating FASD-specific disability benefits, and strengthening community-based programs, long-term outcomes for individuals with FASD can be significantly improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.